Apellis Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing novel therapies to help patients with autoimmune and inflammatory diseases. With a strong pipeline of innovative drugs, Apellis is poised to make a significant impact in the healthcare industry.